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RESPONSES
Glycemic Control and
Hypoglycemia: Is the
Loser the Winner?
Response to Perlmuter et al.
T
heeditorialbyPerlmuteretal.(1)in
the October 2008 issue of Diabetes
Care commented on the long-term
effects of severe hypoglycemia and raised
concerns about our study (2), which re-
ported that within the cohort of subjects
who entered the Diabetes Control and
Complications Trial (DCCT) during ado-
lescence, there was no relationship be-
tween subsequent episodes of severe
hypoglycemia and cognitive performance
measured20yearsafterstudyentry.Be-
low, we outline their ﬁve major concerns
and provide supporting information.
One concern of Perlmuter et al. was
the exclusion of potential participants
from the DCCT if they had a history of
severehypoglycemia,thuslimitinggener-
alizability. However, a history of severe
hypoglycemia was not an absolute exclu-
sion criterion for participation in the
DCCT. Indeed, 24% of the 175 partici-
pantshadpreviouslyexperienced1–5ep-
isodesofseverehypoglycemiawithlossof
consciousness before entry into the
DCCT.
The editorial by Perlmuter et al. also
suggestedthatnonparticipationmayhave
been due to cognitive deterioration or se-
vere hypoglycemic events. However, the
56nonparticipantsremainedactiveinthe
Epidemiology of Diabetes Interventions
and Complications (EDIC) protocol, and
data are available on their frequency of
severe hypoglycemia. The frequency dis-
tribution of severe hypoglycemia episodes
is similar between the 56 nonparticipants
and the 175 participants (5 vs. 9%, respec-
tively). Therefore, dropout due to cognitive
deterioration is unlikely. A comparison of
cognitive performance between baseline
and DCCT year 5 for both groups showed
the same scores on seven domains, with
participantsscoringmodestlybetteronlyon
problem solving (P  0.01).
Perlmuter et al. asserted that baseline
data for the dropouts would have been
useful: There were no differences in de-
mographic or clinical characteristics be-
tween the 175 participants and the 56
nonparticipants at baseline. Complete
baseline data are available upon request.
Perlmuter et al. also stated that our
article was unclear regarding the ages of
the individuals during each severe hypo-
glycemic episode: By EDIC year 12, there
were294eventsin87subjects(33events,
ages 13–16 years; 71, 17–19 years; 152,
20–29 years; and 38, 30–39 years). As
notedonpage1936ofourarticle,thetim-
ingofseverehypoglycemiceventsdidnot
affect performance on any of the eight
cognitive domains evaluated.
Finally, Perlmuter et al. expressed
concern regarding the synergistic ef-
fects of hyperglycemia and hypoglyce-
mia and stated that statistical support
for these effects was not reported. The
synergistic effects of hypoglycemia and
hyperglycemia on cognitive function
were evaluated using the interaction
term in an ANCOVA model. We found
no statistically signiﬁcant effect.
In conclusion, our research question
related to the long-term effects of severe
hypoglycemic episodes on cognitive per-
formance associated with intensive insu-
lin therapy during the DCCT and post-
DCCT period. Our results indicate that
for patients similar to those of the DCCT
adolescent cohort, intensive diabetes
therapy can be implemented without un-
due concern for development of long-
term cognitive deﬁcits during the
follow-upperiod.Despitethisﬁnding,in-
tensive diabetes therapy must be prac-
ticed with caution because severe
hypoglycemia can cause short-term cog-
nitive impairment that affects ability to
carry out daily activities and can lead to
seizure or coma. Moreover, effects of hy-
poglycemia at a younger age were not as-
sessed. In sum, the goal of achieving tight
glycemic control while avoiding severe
hypoglycemia is appropriate for adoles-
cent patients.
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